摘要
基因转染是传递质粒DNA到对各种组织的有效途径。以电脉冲传递分子需要控制电气参数,以实现有效的递送。由于外加高电压可能会出现不适或组织损伤,在实现所期望的表达的同时,降低外加电压可能是一个重要的改进措施。将电转染与外源性的热量相结合是一种可能的途径。在以往的体外进行的研究表明,在用脉冲之前升高温度可以加强基因的表达,并有可能在保持表达水平的同时而降低电场。在这项研究中报道,我们使用一种新颖的,被设计成利用插入激光使其加热的电极装置,来对这种结合在体内进行了评估。本研究结果表明,温度升高时转染的表达增加或外加电压降低时保持了表达的水平。进一步优化这种途径可能为大大提高基因转染的转化方法和新工具提供了依据。
关键词: 基因转染,皮肤,基因治疗,热量,电穿孔
Current Gene Therapy
Title:Thermal Assisted In Vivo Gene Electrotransfer
Volume: 16 Issue: 2
Author(s): Amy Donate, Anna Bulysheva, Chelsea Edelblute, Derrick Jung, Mohammad A. Malik, Siqi Guo, Niculina Burcus, Karl Schoenbach and Richard Heller
Affiliation:
关键词: 基因转染,皮肤,基因治疗,热量,电穿孔
摘要: Gene electrotransfer is an effective approach for delivering plasmid DNA to a variety of tissues. Delivery of molecules with electric pulses requires control of the electrical parameters to achieve effective delivery. Since discomfort or tissue damage may occur with high applied voltage, the reduction of the applied voltage while achieving the desired expression may be an important improvement. One possible approach is to combine electrotransfer with exogenously applied heat. Previous work performed in vitro demonstrated that increasing temperature before pulsing can enhance gene expression and made it possible to reduce electric fields while maintaining expression levels. In the study reported here, this combination was evaluated in vivo using a novel electrode device designed with an inserted laser for application of heat. The results obtained in this study demonstrated that increased temperature during electrotransfer increased expression or maintained expression with a reduction in applied voltage. With further optimization this approach may provide the basis for both a novel method and a novel instrument that may greatly enhance translation of gene electrotransfer.
Export Options
About this article
Cite this article as:
Amy Donate, Anna Bulysheva, Chelsea Edelblute, Derrick Jung, Mohammad A. Malik, Siqi Guo, Niculina Burcus, Karl Schoenbach and Richard Heller , Thermal Assisted In Vivo Gene Electrotransfer, Current Gene Therapy 2016; 16 (2) . https://dx.doi.org/10.2174/1566523216666160331125810
DOI https://dx.doi.org/10.2174/1566523216666160331125810 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Anti-Cancer Agents in Medicinal Chemistry Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
CNS & Neurological Disorders - Drug Targets Nanocarriers for Gene Delivery - Polymer Structure, Targeting Ligands and Controlled-Release Devices
Current Nanoscience Comparative Study of Growth Hormone Treatment in Children with Idiopathic Short Stature and Growth Hormone Deficiency
Current Drug Metabolism Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Inhibitors of Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics The Drug Targeting and Delivery Approach Applied to Pt-Antitumour Complexes. A Coordination Point of View
Current Medicinal Chemistry Antiproliferative and Antifungal Activities of 1,3-diarylpropane-1,3-diones Commonly used as Sunscreen Agents
Letters in Drug Design & Discovery The Peptide Argireline-The Importance of Local Application on the Skin, in the Light of Current Knowledge
Letters in Drug Design & Discovery Bone Changes in Patients with Inflammatory Arthritis Treated with Biological Therapies: A Clinical Perspective
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
Current Organic Synthesis Nicotinic Receptors Containing the α7 Subunit: A Model for Rational Drug Design
Current Medicinal Chemistry PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Current Drug Targets Membrane Targeted Chemotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis
Current Pharmaceutical Design Azidothymidine is Effective Against Human Multiple Myeloma: A New Use for an Old Drug?
Anti-Cancer Agents in Medicinal Chemistry Viral-Mediated Gene Transfer for Cancer Treatment
Current Pharmaceutical Biotechnology Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Inhibiting the Interaction of cMET and IGF-1R with FAK Effectively Reduces Growth of Pancreatic Cancer Cells in vitro and in vivo
Anti-Cancer Agents in Medicinal Chemistry